AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | -98.5% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2022 | $895,000 | -3.0% | 25,707 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $923,000 | +541.0% | 25,707 | +318.1% | 0.00% | – |
| Q4 2021 | $144,000 | +1500.0% | 6,148 | +1254.2% | 0.00% | – |
| Q3 2021 | $9,000 | 0.0% | 454 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | +12.5% | 454 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | -38.5% | 454 | -32.1% | 0.00% | – |
| Q4 2020 | $13,000 | 0.0% | 669 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | -13.3% | 669 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | – | 669 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRIESS ASSOCIATES LLC | 97,760 | $3,401,000 | 5.68% |
| Nantahala Capital Management | 1,000,000 | $34,790,000 | 1.74% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 341,294 | $11,874,000 | 1.52% |
| Portolan Capital Management | 274,889 | $9,563,000 | 0.96% |
| Quantedge Capital Pte Ltd | 121,500 | $4,227,000 | 0.85% |
| SHAKER INVESTMENTS LLC/OH | 37,117 | $1,291,000 | 0.82% |
| GLOBEFLEX CAPITAL L P | 72,253 | $2,514,000 | 0.61% |
| EAM Investors, LLC | 68,855 | $2,395,000 | 0.58% |
| Hillsdale Investment Management Inc. | 197,738 | $6,879,000 | 0.55% |
| Capital Impact Advisors, LLC | 13,835 | $481,000 | 0.44% |